UndisclosedStrategic acquisitionHealthcare & Life Sciences
Hologic to acquire Barcelona's Reveal Genomics
Women's health company Hologic signed a definitive agreement to acquire Reveal Genomics, a Barcelona-based precision oncology firm. Reveal's tests include HER2DX, which helps optimize therapy for HER2-positive breast cancer. Terms were not disclosed in the excerpt.
Why it matters: The deal pushes Hologic further into genomic diagnostics for breast cancer.
Read the full coverage, free
We only link to sources you can read without a subscription. How we check.
Get healthcare deals like this every morning
The day's biggest deals in five minutes. Free, with no paywalled links.